Feed Preview
Influential
HIV: Cell & Gene Therapy
This feed focuses on emerging cell and gene therapies, such as HIV vaccines, for treating patients living with HIV/AIDS. Discover the latest research here.
Top 20 most recent papers
EPP-ASM and the r-hybrid model: new tools for estimating HIV incidence trends in sub-Saharan Africa
AIDSNovember 12, 2019
Jeffrey William EatonTimothy B Hallett
2
Improved Cas9 activity by specific modifications of the tracrRNA
Scientific ReportsNovember 6, 2019
Tristan A ScottKevin V Morris
3
10
Immune effects of Lactobacillus casei Shirota in treated HIV-infected patients with poor CD4+ T cell recovery: a randomized trial
AIDSNovember 9, 2019
Simone de Barros TenoreEsper Georges Kallas
3
IL-7/IL-7R gene variants impact circulating IL-7/IL-7R homeostasis and ART-associated immune recovery status
Scientific ReportsOctober 31, 2019
Andra CeausuAnna Rull
4
Global status of Toxoplasma gondii infection and associated risk factors in people living with HIV: A systematic review and meta-analysis
AIDSNovember 9, 2019
Hanie SafarpourEhsan Ahmadpour
The impact of antiretroviral therapy duration on the HIV-1 infection of T-cells within anatomic sites
Journal of VirologyNovember 13, 2019
Eunok LeeSarah E Palmer
Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosis
AIDSNovember 7, 2019
Tammy M MeyersIMPAACT P1101 Team
Vitamin E is an effective treatment for nonalcoholic steatohepatitis in HIV mono-infected patients
AIDSOctober 16, 2019
Giada SebastianiLIVEHIV Study Group
The HIV protease inhibitor darunavir prevents kidney injury via HIV-independent mechanisms
Scientific ReportsNovember 1, 2019
Xiao-Bo GaoMichael Jordan Ross
2
Attacking Latent HIV with convertibleCAR-T Cells, a Highly Adaptable Killing Platform
CellOctober 31, 2019
Eytan HerzigWarner C. Greene
162
14
3
Timing of and factors associated with HIV disclosure among perinatally infected children in rural Zambia
AIDSOctober 16, 2019
Catherine G SutcliffeWilliam John Moss
The proportion of CD57+ cells among effector CD8+ T cells is lower in HIV controllers compared with antiretroviral therapy-treated patients
AIDSNovember 7, 2019
Soledad HenriquezANRS CO6 PRIMO, the ANRS CO21 CODEX cohorts
HIV Exposure but Not Early CMV Infection is Associated with Increased Hospitalization and Decreased Memory T-cell Responses to Tetanus Vaccine
The Journal of Infectious DiseasesNovember 10, 2019
Christiana Elizabeth SmithAdriana Weinberg
2
Regional brain volumetric changes despite two years of treatment initiated during acute HIV infection
AIDSNovember 12, 2019
Kalpana J KallianpurSEARCH010/RV254 Study Group
4
Summarizing the results and methods of the 2019 UNAIDS HIV estimates
AIDSNovember 12, 2019
Kelsey K CaseJeffrey William Eaton
1
Associations between alcohol use and HIV care cascade outcomes among adults undergoing population-based HIV testing in East Africa
AIDSNovember 12, 2019
Sarah B PuryearGabriel Chamie
3
Decreased growth among antiretroviral drug and HIV exposed uninfected versus unexposed children in Malawi and Uganda
AIDSOctober 12, 2019
Jim AizirePROMISE-NEURODEV study team
2
1
1
Suppression of Zika Virus Infection in the Brain by the Antiretroviral Drug Rilpivirine
Molecular Therapy : the Journal of the American Society of Gene TherapyOctober 11, 2019
Ilker Kudret SariyerKamel Khalili
8
7
1
False-Positive Human Immunodeficiency Virus Type 1 Nucleic Acid Amplification Testing in Chimeric Antigen Receptor T Cell Therapy
Journal of Clinical MicrobiologyNovember 6, 2019
Jocelyn R HauserY i-Wei Tang
1
Diverging trends in incidence of HIV versus other sexually transmitted infections in HIV-negative men who have sex with men (MSM) in Amsterdam
AIDSNovember 9, 2019
Ward Peter Hubertus van BilsenAmy A Matser